Immune checkpoint blockade provokes resident memory T cells to eliminate head and neck cancer.
Cell
; 185(16): 2848-2849, 2022 08 04.
Article
en En
| MEDLINE
| ID: mdl-35931017
ABSTRACT
Immune checkpoint blockade is effective in treating many human cancers. In this issue of Cell, Luoma et al. show that tissue-resident memory T cells in head and neck cancers rapidly respond to immune checkpoint blockade, and they identify specific CD8+ T cells in pretreatment blood that predict pathologic tumor regression.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Linfocitos T CD8-positivos
/
Neoplasias de Cabeza y Cuello
Límite:
Humans
Idioma:
En
Revista:
Cell
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos